Fulgent Genetics
Healthcare Services · California, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
4399 Santa Anita Ave, El Monte, Californ...Phone Number
(626) 350-0537Website
www.fulgentgenetics.comRevenue
$320.3 MillionStock Symbol
FLGTIndustry
ZI Rank: 11
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
8
8
8
7
13
11
About Fulgent Genetics
Founded in 2011, Fulgent has evolved into a premier, full-service genomic testing company built around a foundational technology platform. Through our diverse testing menu, Fulgent is focused on transforming patient care in oncology, anatomic pathology, infectious and rare diseases, and reproductive health. We believe that by providing a wide range of effective, flexible testing options in conjunction with best-in-class service and support, we can redefine the way medicine is managed for patients and clinicians alike. Since integrating with our therapeutic development business, Fulgent is also developing drug candidates for treating a broad range of cancers using a novel nanoencapsulation and targeted therapy platform. By merging our fields of expertise, we aim to become a fully integrated precision medicine company.Explore more
Fulgent Genetics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Fulgent Genetics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Fulgent Genetics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Fulgent Genetics has new funding data
Check if Fulgent Genetics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Fulgent Genetics recently announced quarterly report
Product Launch: Get notified when Fulgent Genetics launches new products
Click to see if Fulgent Genetics had a recent Job posting/layoffs
Check out if Fulgent Genetics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Fulgent Genetics
Recommended Actions
Find VP level buyers at Fulgent Genetics
Find 3 more new buyers
Compare Similar Companies to Fulgent Genetics
Compare insights from companies similar to Fulgent Genetics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Fulgent Genetics
$320.3M
1K - 5K
Public
-
2011
EN
Elias NyankojoVice President Chief Information Security Officer
Company Profile Activity
Activity Insights
Fulgent Genetics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Fulgent Genetics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Fulgent Genetics.
Fulgent Genetics Tech Stack
A closer look at the technologies used by Fulgent Genetics
Most Recent Scoops
Person-Based
Governmental Affairs & Regulation, Contracts, Regulations
Person-Based
Person-Based
Earnings, Finance
Person-Based
Earnings, Finance
Person-Based
Spending/Investment, Healthcare Technology
Fulgent Genetics News & Media
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities LawsLowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities LawsFLGT INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Fulgent Genetics Inc.
NEW YORK, March 23, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP continues its investigation on behalf of Fulgent Genetics Inc. (“Fulgent” or the “Company”) (NASDAQ:FLGT) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws and other unlawful business practices.Latham Watkins Advises on Fulgent Genetics Acquisition of Bako Diagnostics and StrataDX
Multidisciplinary team represents Consonance Capital Partners and laboratory services companies Bako Diagnostics and StrataDx in the transaction.
Read more news
Top Healthcare Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Fulgent Genetics
Sign Up For FreeTo access detailed company insights
Founded in 2011, Fulgent has evolved into a premier, full-service genomic testing company built around a foundational technology platform. Through our diverse testing menu, Fulgent is focused on transforming patient care in oncology, anatomic pathology, infectious and rare diseases, and reproductive health. We believe that by providing a wide range... Read More
